The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae

Lancet Infect Dis. 2022 Sep;22(9):1271-1272. doi: 10.1016/S1473-3099(22)00520-5. Epub 2022 Aug 9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Anti-Bacterial Agents
  • Ceftriaxone
  • Drug Resistance, Bacterial
  • Gonorrhea*
  • Humans
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae*

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone